IRIS
PISATURO, Mariantonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.817
NA - Nord America 4.987
AS - Asia 4.698
SA - Sud America 789
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 21.380
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.565
US - Stati Uniti d'America 4.887
SG - Singapore 1.696
IE - Irlanda 1.293
CN - Cina 855
HK - Hong Kong 793
BR - Brasile 656
VN - Vietnam 587
DE - Germania 420
IT - Italia 404
UA - Ucraina 318
GB - Regno Unito 314
KR - Corea 216
JP - Giappone 157
IN - India 131
FI - Finlandia 106
SE - Svezia 89
TR - Turchia 83
GR - Grecia 77
FR - Francia 65
AR - Argentina 58
CA - Canada 49
BD - Bangladesh 37
AT - Austria 29
IQ - Iraq 29
PL - Polonia 27
ZA - Sudafrica 27
NL - Olanda 21
MX - Messico 19
CO - Colombia 18
PK - Pakistan 18
ES - Italia 16
BE - Belgio 15
ID - Indonesia 15
EC - Ecuador 14
VE - Venezuela 13
MA - Marocco 10
CZ - Repubblica Ceca 9
IR - Iran 9
PE - Perù 8
RS - Serbia 8
AL - Albania 7
EG - Egitto 7
JM - Giamaica 7
JO - Giordania 7
KE - Kenya 7
LT - Lituania 7
UY - Uruguay 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CL - Cile 6
DZ - Algeria 6
EU - Europa 6
PA - Panama 6
TN - Tunisia 6
KZ - Kazakistan 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
HN - Honduras 4
IL - Israele 4
KG - Kirghizistan 4
PH - Filippine 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
SN - Senegal 4
BB - Barbados 3
CM - Camerun 3
GE - Georgia 3
LB - Libano 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CD - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
GA - Gabon 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
Totale 21.369
Salva come PNG Salva come JPEG
Città #
Moscow 2.748
Dublin 1.293
Hong Kong 787
Santa Clara 768
Singapore 702
San Jose 558
Jacksonville 477
Chandler 438
Ashburn 312
Seoul 214
Ho Chi Minh City 180
Bremen 178
Princeton 176
Hanoi 149
Roxbury 146
New York 127
Cambridge 119
Hefei 112
Beijing 110
Dallas 108
The Dalles 82
Ann Arbor 73
Caserta 72
Bengaluru 68
Munich 68
Los Angeles 64
São Paulo 64
Medford 58
Boardman 55
Memphis 48
Wilmington 46
Da Nang 45
Orem 44
Naples 42
Woodbridge 39
San Mateo 33
Washington 29
Des Moines 26
Haiphong 24
Warsaw 23
Nuremberg 22
Chennai 21
Biên Hòa 20
Frankfurt am Main 18
Helsinki 18
Milan 18
Nanjing 18
London 17
Mountain View 16
Rio de Janeiro 16
Tokyo 16
Brasília 15
Brussels 15
Montreal 15
Napoli 15
San Francisco 15
Vienna 15
Johannesburg 14
Jinan 13
Manchester 13
Rome 13
Tianjin 13
Amsterdam 12
Council Bluffs 12
Curitiba 12
Düsseldorf 12
Hillsboro 12
Campinas 11
Denver 11
Hải Dương 11
Istanbul 11
Mumbai 11
Porto Alegre 11
Stockholm 11
Atlanta 10
Belo Horizonte 10
Brooklyn 10
Changsha 10
Chicago 10
Toronto 10
Brno 9
Bến Tre 9
Guangzhou 9
Houston 9
Paris 9
Auburn Hills 8
Aversa 8
Grafing 8
Phoenix 8
Shanghai 8
Shenyang 8
Thái Bình 8
Zhengzhou 8
Boston 7
Caxias do Sul 7
Hangzhou 7
Lappeenranta 7
Nairobi 7
New Delhi 7
Tashkent 7
Totale 11.416
Salva come PNG Salva come JPEG
Nome #
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 206
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 205
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 191
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 191
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 183
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 179
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 176
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 176
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 175
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 166
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 165
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 164
Absence of occult HCV infection in patients experiencing an immunodepression condition 163
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 161
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 161
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 158
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 154
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 151
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 151
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 150
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 150
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 149
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 149
Absence of occult HCV infection in HIV-positive patients 145
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 138
Clinical and virological characteristics associated with severe acute hepatitis B 138
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 138
Risk and prevention of hepatitis b virus reactivation during immunosuppression for non-oncological diseases 138
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 138
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 137
ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENT 137
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 134
A HIGH HBSAG GENETIC COMPLEXITY CAN INFLUENCE HBV IMMUNOGENICITY IN THE SETTING OF ACUTE INFECTION 134
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 134
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 132
Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological Mechanisms 130
F-6 Efficacy and tolerability of peginterferon a-2a and a-2b in patients with chronic hepatitis C by genotype 1: A meta-analysis 130
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 130
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 130
Epidemiology and management of hepatitis C virus infections in immigrant populations 130
A HIGH GENETIC HETEROGENEITY IN HBsAg CAN AFFECT IMMUNOGENICITY IN ACUTE HEPATITIS B INFECTION 128
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 127
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 126
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 126
Absence of occult HCV infection in HIV-positive patients 125
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 124
Bloodstream Infection Due to a VIM-Metallo-β-Lactamase-Producing Klebsiella pneumoniae Treated with Cefiderocol in a Preterm Newborn 124
Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy 124
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 123
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors 122
Clinical Presentation, Outcomes, and Response to Therapy Among Patients with Acute Exacerbation of Chronic Hepatitis C. 122
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 122
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 122
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 121
Virological factors associated with failure to the latest generation of direct acting agents (Daa) and re-treatment strategy: A narrative review 121
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 120
Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases 120
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 118
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic 118
P.216 Molecular analysis of genetic variability and epitope stability in a type 1b recurrent HCV infection 118
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 118
Characterization of hepatitis virus co-infections in a cohort of immigrants living in southern Italy 118
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 116
Role of genetic polymorphisms in hepatitis C virus chronic infection 116
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 115
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 115
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 115
Occult HBV infection in the oncohematological setting. 115
Clinical and virological characteristics associated with severe acute hepatitis B 115
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 114
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 114
The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. 113
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 113
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 113
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 112
Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. 112
T-14 Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection 112
CANNABINOID RECEPTOR 2 (CB2) 63 QQ VARIANT IS ASSOCIATED WITH A SEVERE HISTOLOGICAL ACTIVITY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C 112
Innovative procedures for micro-elimination of HCV infection in persons who use drugs 111
An update on the treatment options for HBV/HCV coinfection 111
Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C 110
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection 110
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial 109
Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: A multicenter observational study 109
Pharmacotherapies for multidrug-resistant gram-positive infections: current options and beyond 109
Infezione da HBV in soggetti immigrati: risultati preliminari di uno studio prospettico multicentrico 108
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 108
The association between education level and chronic liver disease of any etiology 108
Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index 108
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings 106
Management of HBV reactivation in non-oncological patients 106
Role of occult hepatitis B virus infection in chronic hepatitis C 106
COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature 105
Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report 105
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 105
Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index. 104
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment 104
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 104
Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B 103
HDV infection in immigrant populations 103
Totale 13.028
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022913 35 15 2 8 210 13 104 11 23 83 66 343
2022/20232.137 193 56 27 115 299 127 2 102 1.126 15 37 38
2023/2024985 68 23 73 68 350 116 15 26 10 11 48 177
2024/20253.141 9 39 14 86 475 439 387 295 527 456 234 180
2025/202612.683 499 594 649 608 1.079 7.033 673 436 462 293 227 130
Totale 21.714